전임상 의료기기 검사 서비스 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, 검사 모델별, 기기 클래스별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Preclinical Medical Device Testing Services Market Summary

The global preclinical medical device testing services market size was valued at USD 3.4 billion in 2025 and is projected to grow from USD 3.7 billion in 2026 to USD 6.7 billion by 2033, at a CAGR of 8.9% from 2026 to 2033. North America dominated the market, accounting for the largest share of 37.4% in 2025. The market growth is driven by an increasing number of new drug launches, a rise in pharmaceutical R&D activities, growing demand to reduce costs associated with in-house sales, rising complexity in drug commercialization, increasing regulatory oversight, and the ongoing need for cost optimization.

Global Preclinical Medical Device Testing Services Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global preclinical medical device testing services market report based on service, testing model, device class, application, end use, and region:

• Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Biocompatibility Testing Services
  • Material / Chemical Characterization
  • Cytotoxicity Testing
  • Sensitization Testing
  • Irritation & Reactivity Testing
  • Systemic Toxicity Testing
  • Hemocompatibility Testing
  • Implantation Testing
  • Pyrogenicity Testing
  • Others
• Chemistry Testing Services
  • Residuals & Contaminant Analysis
  • Analytical Method Development & Validation
  • Stability & Degradation Studies
  • Other Analytical Chemistry Services
• Microbiology QC Testing Services
  • Sterility Testing & Validation
  • Bioburden Determination
  • Bacterial Endotoxin Testing
  • Others
• Package Validation Services
• Testing Model Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• In Vivo Testing
• In Vitro Testing
• Ex Vivo Testing
• Device Class Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Class I
• Class II
• Class III
• Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Cardiovascular Devices
• Orthopedic Devices
• Dental Devices
• Neurological Devices
• Ophthalmic Devices
• General Surgical Devices
• Aesthetic & Cosmetic Devices
• Others
• End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Medical Device Manufacturers
• CRO & CDMO
• Others
• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Testing Model
  • 1.2.3. Device Class
  • 1.2.4. Application
  • 1.2.5. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Bottom-up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Preclinical Medical Device Testing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Tariff Impact Analysis
• 3.6. Value Chain Analysis
  • 3.6.1. Supply Trends
  • 3.6.2. Demand Trends
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL Analysis

Chapter 4. Preclinical Medical Device Testing Services Market: Service Estimates & Trend Analysis

• 4.1. Preclinical Medical Device Testing Services Market, By Service: Segment Dashboard
• 4.2. Preclinical Medical Device Testing Services Market, By Service: Movement Analysis
• 4.3. Preclinical Medical Device Testing Services Market Estimates & Forecasts, By Service, 2021 - 2033
• 4.4. Biocompatibility Testing Services
  • 4.4.1. Biocompatibility Testing Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.2. Material/Chemical Characterization
    • 4.4.2.1. Material/Chemical Characterization Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.3. Cytotoxicity Testing
    • 4.4.3.1. Cytotoxicity Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.4. Sensitization Testing
    • 4.4.4.1. Sensitization Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.5. Irritation & Reactivity Testing
    • 4.4.5.1. Irritation & Reactivity Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.6. Systemic Toxicity Testing
    • 4.4.6.1. Systemic Toxicity Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.7. Hemocompatibility Testing
    • 4.4.7.1. Hemocompatibility Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.8. Implantation Testing
    • 4.4.8.1. Implantation Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.9. Pyrogenicity Testing
    • 4.4.9.1. Pyrogenicity Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.4.10. Others
    • 4.4.10.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 4.5. Chemistry Testing Services
  • 4.5.1. Chemistry Testing Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.5.2. Residuals & Contaminant Analysis
    • 4.5.2.1. Residuals & Contaminant Analysis Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.5.3. Analytical Method Development & Validation
    • 4.5.3.1. Analytical Method Development & Validation Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.5.4. Stability & Degradation Studies
    • 4.5.4.1. Stability & Degradation Studies Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.5.5. Other Analytical Chemistry Services
    • 4.5.5.1. Other Analytical Chemistry Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 4.6. Microbiology QC Testing Services
  • 4.6.1. Microbiology QC Testing Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.6.2. Sterility Testing & Validation
    • 4.6.2.1. Sterility Testing & Validation Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.6.3. Bioburden Determination
    • 4.6.3.1. Bioburden Determination Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.6.4. Bacterial Endotoxin Testing
    • 4.6.4.1. Bacterial Endotoxin Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
  • 4.6.5. Others
    • 4.6.5.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 4.7. Package Validation Services
  • 4.7.1. Package Validation Services Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 5. Preclinical Medical Device Testing Services Market: Testing Model Estimates & Trend Analysis

• 5.1. Preclinical Medical Device Testing Services Market, By Testing Model: Segment Dashboard
• 5.2. Preclinical Medical Device Testing Services Market, By Testing Model: Movement Analysis
• 5.3. Preclinical Medical Device Testing Services Market Estimates & Forecasts, By Testing Model, 2021 - 2033
• 5.4. In Vivo Testing
  • 5.4.1. In Vivo Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 5.5. In Vitro Testing
  • 5.5.1. In Vitro Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 5.6. Ex Vivo Testing
  • 5.6.1. Ex Vivo Testing Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 6. Preclinical Medical Device Testing Services Market: Device Class Estimates & Trend Analysis

• 6.1. Preclinical Medical Device Testing Services Market, By Device Class: Segment Dashboard
• 6.2. Preclinical Medical Device Testing Services Market, By Device Class: Movement Analysis
• 6.3. Preclinical Medical Device Testing Services Market Estimates & Forecasts, By Device Class, 2021 - 2033
• 6.4. Class I
  • 6.4.1. Class I Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 6.5. Class II
  • 6.5.1. Class II Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 6.6. Class III
  • 6.6.1. Class III Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 7. Preclinical Medical Device Testing Services Market: Application Estimates & Trend Analysis

• 7.1. Preclinical Medical Device Testing Services Market, By Application: Segment Dashboard
• 7.2. Preclinical Medical Device Testing Services Market, By Application: Movement Analysis
• 7.3. Preclinical Medical Device Testing Services Market Estimates & Forecasts, By Application, 2021 - 2033
• 7.4. Cardiovascular Devices
  • 7.4.1. Cardiovascular Devices Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 7.5. Orthopedic Devices
  • 7.5.1. Orthopedic Devices Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 7.6. Dental Devices
  • 7.6.1. Dental Devices Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 7.7. Neurological Devices
  • 7.7.1. Neurological Devices Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 7.8. Ophthalmic Devices
  • 7.8.1. Ophthalmic Devices Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 7.9. General Surgical Devices
  • 7.9.1. General Surgical Devices Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 7.10. Aesthetic & Cosmetic Devices
  • 7.10.1. Aesthetic & Cosmetic Devices Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 7.11. Others
  • 7.11.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 8. Preclinical Medical Device Testing Services Market: End Use Estimates & Trend Analysis

• 8.1. Preclinical Medical Device Testing Services Market, By End Use: Segment Dashboard
• 8.2. Preclinical Medical Device Testing Services Market, By End Use: Movement Analysis
• 8.3. Preclinical Medical Device Testing Services Market Estimates & Forecasts, By End Use, 2021 - 2033
• 8.4. Medical Device Manufacturers
  • 8.4.1. Medical Device Manufacturers Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 8.5. CRO & CDMO
  • 8.5.1. CRO & CDMO Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)
• 8.6. Others
  • 8.6.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million/Billion)

Chapter 9. Preclinical Medical Device Testing Services Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Dashboard
• 9.2. Regional Market Share Analysis, 2025 & 2033
• 9.3. North America
  • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.4. Europe
  • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.5. Thailand
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.6. South Korea
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.7. Australia
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.6. Latin America
  • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.7. MEA
  • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.6. Oman
    • 9.7.6.1. Key Country Dynamics
    • 9.7.6.2. Competitive Scenario
    • 9.7.6.3. Regulatory Framework
    • 9.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.7. Qatar
    • 9.7.7.1. Key Country Dynamics
    • 9.7.7.2. Competitive Scenario
    • 9.7.7.3. Regulatory Framework
    • 9.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 10. Competitive Landscape

• 10.1. Key Participant Categorization
  • 10.1.1. Market Leaders
  • 10.1.2. Emerging Players
• 10.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 10.3. Company Profiles
  • 10.3.1. SGS SA
    • 10.3.1.1. Company Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Service Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Eurofins Scientific
    • 10.3.2.1. Company Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Service Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Pace Analytical Services LLC
    • 10.3.3.1. Company Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Service Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Intertek Group Plc
    • 10.3.4.1. Company Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Service Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. WUXI APPTEC
    • 10.3.5.1. Company Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Service Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. TUV SUD AG
    • 10.3.6.1. Company Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Service Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. Sterigenics International LLC (Nelson Labs)
    • 10.3.7.1. Company Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Service Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. North American Science Associates, Inc.
    • 10.3.8.1. Company Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Service Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Charles River Laboratories International, Inc.
    • 10.3.9.1. Company Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Service Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Labcorp Drug Development
    • 10.3.10.1. Company Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Service Benchmarking
    • 10.3.10.4. Strategic Initiatives